Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856



 Company News
Omeros Corporation (OMER) Release: OMS721 Inhibits Thrombus Formation In Sera from aHUS Patients 11/19/2014 12:32:36 PM
Omeros Corporation (OMER) Reports Third Quarter 2014 Financial Results 11/11/2014 7:42:46 AM
Omeros Corporation (OMER) Announces Positive Data for MASP-2 Inhibitor In Experimental Model Of Stroke 11/6/2014 6:20:26 AM
Omeros Corporation (OMER) To Announce Third Quarter 2014 Financial Results On November 10, 2014 11/4/2014 8:49:34 AM
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014 8:14:36 AM
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014 5:41:25 AM
Omeros Corporation (OMER) Reports Second Quarter 2014 Financial Results 8/12/2014 8:39:47 AM
Omeros Corporation (OMER) To Present At The Wedbush Pacgrow 2014 Life Sciences Management Access Conference 8/8/2014 8:40:36 AM
Omeros Corporation (OMER) Receives FDA Approval Of Omidria™ For Use In Cataract And Other Intraocular Lens Replacement Procedures 6/2/2014 6:49:25 AM
Omeros Corporation (OMER) Reports First Quarter 2014 Financial Results 5/13/2014 6:26:46 AM